Global Radiofrequency Ablation Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Radiofrequency Ablation Market Insights, Forecast to 2034
This report studies the Radiofrequency Ablation market, Radiofrequency ablation (RFA) is a medical procedure in which part of the electrical conduction system of the heart, tumor or other dysfunctional tissue is ablated using the heat generated from medium frequency alternating current (in the range of 350–500 kHz).
Market Analysis and InsightsGlobal Radiofrequency Ablation Market
Global Radiofrequency Ablation market is expected to reach to US$ 4231 million in 2023, with a positive growth of %, compared with US$ 3905 million in 2022. Backed with the increasing demand from downstream industries, Radiofrequency Ablation industry is evaluated to reach US$ 7828.6 million in 2033. The CAGR will be 10.8% during 2023 to 2033.
Rising number of cases of cardiovascular diseases and cancers (lung cancer, liver cancer, kidney cancer, bone cancer, hepatocellular carcinoma, pancreatic cancer, bile duct cancer, etc.) across the globe is one of the key reasons driving the market growth. Apart from rising number of cases of cancer and cardiovascular diseases, rising demand for pain management, such as medications to relieve arthritis and other chronic pain disorders, is also largely driving the growth of the overall market. In addition, the elderly are more prone to chronic diseases and the continuous growth of the global geriatric population is one of the key factors driving the market growth.
Report Covers
This report presents an overview of global Radiofrequency Ablation market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Radiofrequency Ablation market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
AngioDynamics
Boston Scientific
Medtronic
Abbott
Stryker
Accuray
Advanced Cardiac Therapeutics
Segment by Type
Disposable Equipment
Reusable Equipment
Hospitals
ASCs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Radiofrequency Ablation introduction, etc. Radiofrequency Ablation Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Radiofrequency Ablation
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Radiofrequency Ablation Market
Global Radiofrequency Ablation market is expected to reach to US$ 4231 million in 2023, with a positive growth of %, compared with US$ 3905 million in 2022. Backed with the increasing demand from downstream industries, Radiofrequency Ablation industry is evaluated to reach US$ 7828.6 million in 2033. The CAGR will be 10.8% during 2023 to 2033.
Rising number of cases of cardiovascular diseases and cancers (lung cancer, liver cancer, kidney cancer, bone cancer, hepatocellular carcinoma, pancreatic cancer, bile duct cancer, etc.) across the globe is one of the key reasons driving the market growth. Apart from rising number of cases of cancer and cardiovascular diseases, rising demand for pain management, such as medications to relieve arthritis and other chronic pain disorders, is also largely driving the growth of the overall market. In addition, the elderly are more prone to chronic diseases and the continuous growth of the global geriatric population is one of the key factors driving the market growth.
Report Covers
This report presents an overview of global Radiofrequency Ablation market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Radiofrequency Ablation market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
AngioDynamics
Boston Scientific
Medtronic
Abbott
Stryker
Accuray
Advanced Cardiac Therapeutics
Segment by Type
Disposable Equipment
Reusable Equipment
Segment by Application
Hospitals
ASCs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Radiofrequency Ablation introduction, etc. Radiofrequency Ablation Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Radiofrequency Ablation
Chapter 13Methodology and Data Sources adopted by MRAResearch